Effects of resistance exercise on blood glucose in post-menopausal women with type 1 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how resistance exercise impacts blood glucose levels in post-menopausal women diagnosed with type 1 diabetes. It addresses the significant barriers to physical activity in this population, particularly the fear of hypoglycemia during and after exercise. The research will involve participants performing high and moderate repetition resistance exercises to assess their effects on glucose management. The study aims to fill the knowledge gap regarding exercise recommendations for women with type 1 diabetes, especially after menopause.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* female
* type 1 diabetes diagnosed for at least 1 year
* at least 12 months since last menstrual period
* physically able and willing to perform resistance exercise
* HbA1c \< 10%
* residing near Edmonton, Alberta / able to attend laboratory based sessions at the University of Alberta

Exclusion Criteria:

* Individuals with HbA1c \>9.9%
* Frequent and unpredictable hypoglycaemia
* A change in insulin management strategy within two months of the study
* Blood pressure \> 144/95,
* Severe peripheral neuropathy,
* A history of cardiovascular disease
* Musculoskeletal injuries affecting the ability to perform resistance exercise.
* Individuals who are treated with medications (other than insulin) that affect glucose metabolism (e.g. atypical antipsychotics, corticosteroids)
* A body mass index \>30kg/m2,
* Smoking
* Moderate to high alcohol intake (\>2 drinks per day)

Where it's running

• Alberta Diabetes Institute
  Edmonton, Alberta, Canada Recruiting

Study contacts

• Study coordinator: Jane Yardley, PhD
• Email: jane.yardley@ualberta.ca
• Phone: 780-679-1688

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Semaglutide on body composition in adults with type 1 diabetes and overweight/obesity

  This study tests whether weekly semaglutide changes body composition in adults with type 1 diabetes who are overweight or obese, compared with a placebo over 24 weeks.

  Recruiting Phase 2/3 McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT07891156

• Next Generation Extended Wear Sensors in Type 1 and Type 2 Diabetes

  This study tests a new extended wear sensor and algorithm in people with type 1 or type 2 diabetes to see how well it works across adults and children.

  Recruiting at 11 sites Medtronic MiniMed, Inc. · Chula Vista, California and 17 other locations · NCT07864168

• CGM-guided carb awareness education for adults with Type 1 diabetes

  This study tests whether teaching mealtime insulin dosing using CGM data helps adults with Type 1 diabetes who don’t usually count carbs.

  Recruiting University of California, Los Angeles · Los Angeles, California · NCT07807280

• Safety and effectiveness of GLP-1 receptor agonists and SGLT inhibitors added to insulin in adults with type 1 diabetes

  This registry will see if adding GLP-1RA or SGLTi therapies to insulin helps adults with type 1 diabetes over one year.

  Recruiting at 17 sites Indiana University · Newport Beach, California and 16 other locations · NCT07676565

• Think-Find-Solve activities for insulin self-management in children with type 1 diabetes

  A behavior-change activity book is tested with children aged 8–12 with type 1 diabetes and their parents to see if it improves daily insulin self-management.

  Recruiting Marmara University · Istanbul · NCT07670572

• Near-sensor insulin delivery with CGM in people with type 1 diabetes

  A small early-feasibility study tests a dual-port insulin patch pump that includes a CGM sensor to see if delivering insulin near the sensor affects glucose readings and whether an automated control algorithm can manage glucose.

  Recruiting Early Phase 1 ClinSurge Research · Toronto, Ontario · NCT07655076

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.